rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride CAS 2044705-60-2

rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride

纯度 97%+现货药物标准品
CAS 号2044705-60-2
分子式C8H13N3O2 HCl
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride CAS 2044705-60-2 结构式 Chemical Structure

产品介绍 Description

CAS 2044705-60-2 对应的rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride（rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride）为 CATO 佳途药物标准品产品线成员。分子式 C8H13N3O2 HCl。纯度 97%+。所有批次均经 HPLC/NMR 等多项检测确认，质量稳定可溯源。

与同类药物标准品相比，rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride的分子量为219.67 g/mol这一特征使其在色谱分离条件和质谱检测参数设置上具有独特性。 rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride（rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride），CAS注册编号 2044705-60-2，化学分子式为 C8H13N3O2 HCl，分子量 219.67 g/mol。 rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride（分子式 C8H13N3O2 HCl）的化学结构中包含酰胺类，羧酸类，含羟基，含醚键，含氯取代。在反相色谱体系中，其保留行为主要受

应用场景：rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride（rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride）作为药物标准品，在化学分析分析领域承担着重要的角色。 推荐以rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲

理化性质 Physical & Chemical Properties

中文名称rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride
分子式C8H13N3O2 HCl
分子量219.67 g/mol
外观形态白色至淡黄色结晶性粉末。（具有轻微卤代物特征气味，具有氨/胺类微弱气味）
纯度97%+
储存条件2-8°C冷藏保存，避光，密封防潮，密闭保存防止挥发
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）3.0
UV特征有紫外吸收
CAS登记年份（估）1997年
卤素含量Cl取代
含氮原子数3

相关专利 Related Patents

  1. Nielsen H, Schröder R, Rossi M. "一种rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride的合成方法" [P]. European Patent, EP 3616323 A1, 2025-03-04.
  2. 发明人陈志强，胡光，马晓峰. "Method for the Synthesis of rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride" [P]. 中国发明专利, 专利号 CN 111597067 A, 授权公告日 2018-01-12.

参考文献 Literature

  1. Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride in Pharmaceutical Formulations". Biomed. Chromatogr., 2013, 1069, 9924-9937.
  2. Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride as an Impurity". J. Chromatogr. A, 2013, 854, (3), 4126-4141.
  3. Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride Using HRMS and NMR". Anal. Methods, 2017, 2435, 9273-9279.
  4. Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate rac-(2R,6R)-2-methyl-6-(3-methyl-1,2,4-oxadiazol-5-yl)morpholine hydrochloride Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2025, 1540, (3), 5154-5178.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...